Seer, Inc. (SEER) Fair Value 2026

SEER · Biotechnology ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.0 /10

32 fundamental signals · 1 models active

Value Trap Risk

SAFE (19/100)

Quick Summary — As of 2026-08-28, Seer, Inc. (SEER) trades at $1.98. QOC: 7.0/10. Value Trap Risk: 19/100 (SAFE). 1/13 models active.

Key Facts

Ticker
SEER
Price
$1.98
Quality Score
7.0/10
Value Trap Risk
19/100
Models Active
1/13
Last Updated
Strength: Dynamic NAV suggests +20.3% upside with 50% confidence
Risk: Limited model coverage (1/13) may reduce confidence

What Fair Value Does Each Model Give SEER?

1 Intrinsic Value Models vs. Current Price ($1.98)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · Medium Conviction
 $2.38 +20.3%

All Models Active

All 1 models are displayed above.

What Is Seer, Inc. (SEER) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Seer, Inc.. Trading at $1.98 against an estimated intrinsic value of $2.38, 1 of 1 active models flag meaningful upside of +20.3% at the median.

What Do the Models Say About SEER?

1 of 13 models are currently active for SEER. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does SEER Rank in Biotechnology?

Among 625 Biotechnology stocks, SEER ranks #46 by Quality of Company score. CirclFi's QOC score of 7.0/10 evaluates 32 fundamental signals. A score of 7.0 indicates above-average quality.

See all Most Undervalued Biotechnology Stocks →

As a biotech sector, Seer, Inc. operates in a sector where partnership revenue is a critical driver of valuation. Investors evaluating SEER should weigh these sector-specific dynamics alongside our model-derived fair values.

Is SEER a Value Trap?

CirclFi's Value Trap algorithm assigns SEER a score of 19/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Seer, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Seer, Inc.'s fundamental quality profile registers 7.0/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SEER valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SEER's 1 active models, average confidence is 50%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Seer, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

11 related Biotechnology stocks with 13-model coverage

MRNAModerna, Inc.QOC 7.0MGTXMeiraGTx Holdings plcQOC 7.0URGNUroGen Pharma Ltd.QOC 7.1ANABAnaptysBio, Inc.QOC 7.0ABUSArbutus Biopharma CorporationQOC 7.1PRTAProthena Corporation plcQOC 7.0SCNIScinai Immunotherapeutics Ltd.QOC 5.6PGENPrecigen, Inc.QOC 4.9RNTXRein Therapeutics Inc.QOC 4.2EXELExelixis, Inc.QOC 9.6INCYIncyte CorporationQOC 9.5

Read investment analysis: MRNA · MGTX · URGN · ANAB · ABUS · PRTA · SCNI · PGEN · RNTX · EXEL · INCY

Which Other Stocks Have a Similar Quality Score to SEER?

7 companies across all industries closest to SEER’s Quality of Company score of 7.0/10.

WFWoori Financial Group Inc.QOC 7.0KODKEastman Kodak CompanyQOC 7.0CDLRCadeler A/SQOC 7.0BCBPBCB Bancorp, Inc.QOC 7.0AMBAAmbarella, Inc.QOC 7.0KEPKorea Electric Power CorporationQOC 7.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: WF · KODK · CDLR · BCBP · AMBA · KEP · NVDA

Where Does SEER Sit in CirclFi's Biotechnology Rankings?

SEER is ranked against every other Biotechnology stock CirclFi covers in each of these screens.

See all Biotechnology stocks ranked →

What Else Do Investors Ask About Seer, Inc.’s Valuation?

What is Seer, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Seer, Inc. (SEER). The Quality of Company score is 7.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SEER overvalued or undervalued right now?

At $1.98, 1 of 1 active models suggest SEER may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Seer, Inc.'s business model in Biotechnology.

What does a Quality of Company score of 7.0 mean for SEER?

Seer, Inc.'s QOC of 7.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on SEER?

CirclFi analyzes SEER with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is SEER a value trap in 2026?

Seer, Inc.'s Value Trap score is 19/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Seer, Inc. (SEER) a Quality of Company score of 7.0/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/SEER/ · Methodology
Primary sources for this SEER valuation
  • Financial statements: Seer, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001726445) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SEER as of ; valuations recomputed .